Recent Updates
Recently added Catalysts
DRIO

DarioHealth to Present at Chardan

Key Takeaway: SAN FRANCISCO, May 21, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that Erez Raphael, Chairman and CEO of DarioHealth, will be delivering a presentation at Chardan's Digi

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
Medium dilution risk
Lead asset
skin
Phase 3 · Post-surgery Radiotherapy

Full Press Release Details

SAN FRANCISCO, May 21, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that Erez Raphael, Chairman and CEO of DarioHealth, will be delivering a presentation at Chardan's Digital Health Conference.
Chardan's Digital Health Conference
Location: Le Meridien, B-Level, San Francisco
Presenter: Erez Raphael, Chairman and CEO
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital health company serving its users with dynamic mobile health solutions. In today's day and age, knowledge of health and treatment is being democratized, and we believe people deserve to know everything about their own health and have the best tools to manage their condition. DarioHealth employs a revolutionary approach whereby harnessing big data, we have developed a novel method for chronic disease data management, empowering people to analyze and personalize self-diabetes management in a totally new way without having the disease slow them down. DarioHealth has a commercial office in New York with an R&D center in Caesarea, Israel. For more information, visit http://mydario.investorroom.com/.
Last updated: May 21, 2018